Oncology Research and Treatment

Papers
(The TQCC of Oncology Research and Treatment is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 202326
PharmaNews25
Polypharmazie - Wechselwirkungen der BTKi24
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience24
uGI: Biomaker-Cut-Offs in der Immunonkologie22
Front & Back Matter20
PharmaNews18
Front & Back Matter18
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab17
Follow-up time of anal cancer screening among women living with HIV at high risk of developing anal cancer16
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study15
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease13
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial13
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient selection and surgical management in advanced ovarian cancer: what tools do we have to make the right decision?12
Society Bulletins12
Society Bulletins12
Body Composition and Inflammation as emerging Sex-specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma undergoing Immune Checkpoint-Inhibition Therapy – a Prospective Pilot Study11
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis11
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice10
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis8
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy8
Career and Professional Development for Young Oncologists8
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem7
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors7
Front & Back Matter7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center7
PharmaNews7
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine7
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer6
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 756
DKK 2024: Acalabrutinib im Praxis-Check6
Sustained clinical response to Olaparib in a patient with metastatic pancreatic cancer and somatic ATM-Mutation R2034Ter: a case report6
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz6
PharmaNews6
OnkoImmun 216
Front & Back Matter6
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany6
Front & Back Matter5
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer5
PharmaNews5
NSCLC: RWE-Daten zur Sequenztherapie5
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors5
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial5
Society Bulletins5
Erratum5
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer5
PharmaNews5
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative5
Epcoritamab: Indikationserweiterung für das FL5
Vorwort des DGHO-Vorstands5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology5
Management of Advanced Penile Cancer4
A current assessment of the use of complementary medicine in German cancer patients - the CONKO 022 investigation4
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report4
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%4
Society Bulletins4
PharmaNews4
PharmaNews4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality4
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein4
Prelims4
Therapiemanagement von Sacituzumab Govitecan4
Durvalumab auch bei Hirnmetastasen vorteilhaft4
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL4
Perspectives for Cancer Care and Research in Central and Eastern Europe4
Das inoperable NSCLC im Stadium III im Dialog3
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation3
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models3
Erratum3
PharmaNews3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
Psychological stress in breast cancer patients during the course of a pandemic disease – before and after the availability of vaccines3
Risk and Prognosis of Subsequent Primary Gastric Cancer3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen3
Oncology in Europe3
Prognosis and Therapy of Ovarian Cancer, Part 2: the shifting landscape of medical treatment in ovarian cancer3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi3
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich2
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey2
PharmaNews2
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment2
Prelims2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie2
PharmaNews2
Guidelines of Onkopedia: What is new? Esophageal Cancer2
Front & Back Matter2
Society Bulletins2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review2
Society Bulletins2
Nintedanib und Docetaxel beim Adenokarzinom der Lunge2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20232
Society Bulletins2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study2
Society Bulletins2
OnkoImmun 192
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis2
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study2
Nivolumab plus Ipilimumab beim metastasierten Melanom2
Society Bulletins2
Front & Back Matter1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database1
Real World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A retrospective single-center analysis 2010 - 20181
PharmaNews1
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines1
Acknowledgement to Reviewers1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis1
Front & Back Matter1
Society Bulletins1
ALL - Blinatumomab verbesserte die Prognose für Kinder1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast1
Contents Vol. 47, 20241
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel1
Prognostic Significance of HER2 Positivity in Endometrium Cancer1
Society Bulletins1
Prelims1
Recent Advances in Castleman Disease1
Erweiterte Therapieoptionen bei EGFRm NSCLC1
Front & Back Matter1
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
PharmaNews1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis1
Front & Back Matter1
OnkoImmun 181
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study1
Management of Patients Undergoing CAR-T Cell Therapy in Germany1
Society Bulletins1
PharmaNews1
Onkologische Patient*innen individuell behandeln und begleiten1
PharmaNews1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma1
0.05206298828125